Improving the use of a calcineurin-inhibitor free immunosuppression by monitoring kidney transplant toxicity and inflammation in the urine sediment
The drugs that best protect against the rejection of a transplanted kidney cause damage to the organ itself through toxic side effects. As a result, the transplants survive for a shorter time. Therefore, a switch to a different immunosuppression is often attempted. However, only around half of those treated benefit from this and the rate of rejection also increases slightly.